Cargando…
A Budget-Impact and Cost-Effectiveness Model for Second-Line Treatment of Major Depression
BACKGROUND: Depressed patients who initially fail to achieve remission when placed on a selective serotonin reuptake inhibitor (SSRI) may require a second treatment. OBJECTIVES: The purpose of this study was to evaluate the effectiveness, cost, cost-effectiveness, and budget impact of second-line ph...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437458/ https://www.ncbi.nlm.nih.gov/pubmed/17874482 http://dx.doi.org/10.18553/jmcp.2007.13.s6-a.8 |